Quote:
Originally Posted by The Slim Reaper
(Post 11221654)
Again, it didn't. Under EU law, countries are permitted to act independently to approve vaccines. Other countries within the EU did the same thing. This has been done to death, so I thought the lies about it had stopped, but I didn't allow for you, I guess. :laugh:
|
https://www.politico.eu/article/euro...h-astrazeneca/
How Europe fell behind on vaccines
Heralded for months as the flagship of European solidarity during the coronavirus pandemic, the European Commission’s strategy of joint vaccine procurement is now being accused by national leaders of being too bureaucratic, too limiting to its members, too slow.
Specifically, the bloc’s decisions to prioritize process over speed and to put solidarity between EU countries ahead of giving individual governments more room to maneuver have been criticized for holding back the coronavirus response.
This account is based on dozens of interviews with diplomats, Commission officials, pharma industry representatives and national government aides. It details how the European Commission overcame a disorganized start to lead reluctant member countries in a successful effort to reserve an arsenal of vaccines that’s the envy of the world when it comes to cost and the diversification of smart bets.
It also shows how a vaccine strategy that was supposed to be a forceful show of European solidarity, an assertion of the single market’s buying power and a moral stand against Trumpian “vaccine nationalism” resulted in a rollout that has left the EU lagging behind the United Kingdom and the United States.
EU countries stuck together even as the U.S. and the U.K. bought, approved and began injecting vaccines at a faster clip. The result: lower prices, with higher accountability for drugmakers, and shots for the whole of the EU — but also delays in delivery and rising tensions among EU member countries resentful about the tradeoffs.
Over the past 10 months of the global vaccine race, the EU was often a step or two behind: Its move to secure doses came only after warnings that the U.S. might monopolize supply. Its deliberative approach to regulatory approval has left EU citizens lagging behind the U.S. and the U.K. when it comes to getting access to vaccines — at a moment when delays are counted in lost lives.....
......
I'll not call you a liar for believing differently - there was no need call me one. :wavey:
|